Home › HiberGene Gets CE Mark for Rapid Flu Combo MDx

HiberGene Gets CE Mark for Rapid Flu Combo MDx

Dec 13, 2018

NEW YORK (GenomeWeb) – HiberGene Diagnostics said today that it has received CE marking for its HG Flu A/B Combo test and has launched it in Europe, Asia, and South America.

The test uses nasopharyngeal swabs for the direct detection of the influenza virus and provides a differential diagnosis between the A and B subtypes to facilitate best treatment options.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Featured Webinar

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

What's Popular?

In Molecular Diagnostics

  1. Foundation Medicine Says Tumor Mutational Burden Reporting Issue on CDx Test Is Resolved

  2. Minimal Residual Disease Sequencing Poised to Grow Following Lag in Adoption

    Premium

  3. Predigen Diagnostics Developing Gene Expression Platform to Differentiate Bacterial from Viral Infections

    Premium

  4. BioMérieux, DiaSorin, GenMark, and Others Receive FDA Clearances in December

  5. Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.